FDA Identifies Excipients At Risk for Potential Melamine Contamination
This article was originally published in The Gold Sheet
Executive Summary
Which excipients might be vulnerable to melamine substitution? FDA provides its list of 23 at-risk excipients and recommends specific steps for safeguarding them.
You may also be interested in...
Dismissing Requests of World’s Gelatin Makers, FDA Asks USP to Add Tests for Melamine to Monograph
Undeterred by arguments from gelatin manufacturers that there is no economic motivation to put melamine in gelatin, FDA asks USP to require additional testing for the potential adulterant.
Dismissing Requests of World’s Gelatin Makers, FDA Asks USP to Add Tests for Melamine to Monograph
Undeterred by arguments from gelatin manufacturers that there is no economic motivation to put melamine in gelatin, FDA asks USP to require additional testing for the potential adulterant.
FDA Intends To Strengthen Recall Effectiveness Checks
McKinsey & Co’s. study recommends FDA accelerate internal communications about recalls and consider outsourcing audit checks to follow-up on more. FDA commissioned the study after the heparin recall in 2008 and the peanut products recall in 2009 revealed flaws in the agency’s system.